ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
03/02/2021 - 08:00 AM
ANN ARBOR, MI / ACCESSWIRE / March 2, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS® ), announces that management will participate in two upcoming virtual investment conferences.
H.C. Wainwright Global Life Sciences Virtual Conference, March 9-10, 2021. Management will deliver a company presentation and will be available for one-on-one meetings. A webcast of the recorded presentation will be accessible on demand beginning Tuesday, March 9, 2021 for registered participants of the conference. 33rd Annual ROTH Conference, March 15-19, 2021. Management will deliver a company presentation and will be available for one-on-one meetings. A webcast of the recorded presentation will be available on demand in the Investors section of ENDRA Life Sciences' website starting March 8, 2021. About ENDRA Life Sciences Inc. ® ), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with the over 1 million ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over 1 billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS® , including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com .
Company Contact: investors@endrainc.com
Investor Relations Contact: kgolodetz@lhai.com
SOURCE: ENDRA Life Sciences Inc.
View source version on accesswire.com:
https://www.accesswire.com/632459/ENDRA-Life-Sciences-to-Participate-in-Two-Upcoming-Investment-Conferences
NDRA Rankings
N/A Ranked by Stock Gains
NDRA Stock Data
Industry
Electromedical and Electrotherapeutic Apparatus Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Surgical and Medical Instrument Manufacturing
About NDRA
endra life sciences is bringing new capabilities to ultrasound. our photo-acoustic solutions help medical researchers screen and modify disease models with unparalleled quality and speed. we’re proud to have a global installed base of leading institutions using our nexus-128 system, the only 3d imaging solution for imaging anatomy, physiology and labeled molecular targets. the nexus 128 is a preclinical photoacoustic computed tomography (ct) scanner for small animal imaging. the system is used for simple, fast, non-invasive quantification of physiological parameters such as tumor vasculature without ionizing radiation. the fully-3d imaging technology used by the nexus 128 provides increased sensitivity compared to slice-based scanners, and dynamic (4-d) photoacoustic ct scans allow for applications such as quantification of probe uptake. the nexus 128 is currently being used by top imaging laboratories around the globe.
